Patrick Serruys

Showing 1-20 of 529 articles

Coronary interventions

Impact of clinical and hemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries - A patient level pooled analysis of the DEBATE and ILIAS studies

Stegehuis VE, Wijntjens GW, Bax M, Meuwissen M, Chamuleau SA, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

January 21, 2020 | 10.4244/EIJ-D-19-00774

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Tomaniak M, Storey R, Serruys P

January 17, 2020 | 10.4244/EIJY19M10_01

Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Chang C, Kogame N, Onuma Y, Byrne R, Capodanno D, Windecker S, Morel M, Cutlip D, Krucoff M, Stone G, Lansky A, Mehran R, Spitzer E, Fraser A, Baumbach A, Serruys P

January 17, 2020 | 10.4244/EIJ-D-19-00552

Coronary interventions

The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

January 17, 2020 | 10.4244/EIJ-D-19-00467

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Very long-term outcome of ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kočka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M, Gómez-Hospital J, Hurtado J, Valdes M, Widimsky P

December 17, 2019 | 10.4244/EIJ-D-19-00773

Coronary interventions

Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial

Tomaniak M, Chichareon P, Modolo R, Takahashi K, Chang C, Kogame N, Spitzer E, Buszman P, van Geuns R, Valkov V, Steinwender C, Geisler T, Prokopczuk J, Sabaté M, Zmudka K, Rademaker-Havinga T, Tijssen J, Jüni P, Hamm C, Steg G, Onuma Y, Vranckx P, Valgimigli M, Windecker S, Baber U, Anderson R, Dominici M, Serruys P

December 17, 2019 | 10.4244/EIJ-D-19-00699

Coronary interventions

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik III JF, Kappetein AP, Dressler O, Stone G

December 3, 2019 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of Final Kissing Balloon Inflation on Long-term Outcomes After PCI of Distal Left Main Bifurcation Lesions: Analysis From the EXCEL Trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein AP, Sabik III JF, Dressler O, Mehran R, Sharma SK, Stone G

November 26, 2019 | 10.4244/EIJ-D-19-00851

Interventions for valvular disease

Quantitative aortography assessment of aortic regurgitation. Insight into a novel technique

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J-P, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Sandoli de Brito Jr F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

November 20, 2019 | 10.4244/EIJ-D-19-00879

Coronary interventions

Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F-J, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

November 20, 2019 | 10.4244/EIJ-D-19-00866

Coronary interventions

The Obesity Paradox Revisited: Body Mass Index and Long-Term Outcomes After PCI From a Large Pooled Patient-Level Database

Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G

October 29, 2019 | 10.4244/EIJ-D-19-00467

The SYNTAX score on its way out or … towards artificial intelligence: part I

Serruys P, Chichareon P, Modolo R, Leaman D, Reiber J, Emanuelsson H, Di Mario C, Pijls N, Morel M, Valgimigli M, Farooq V, van Klaveren D, Capodanno D, Andreini D, Bourantas C, Davies J, Banning A, Escaned J, Piek J, Echavarría-Pinto M, Taylor C, Thomsen B, Collet C, Pompilio G, Bartorelli A, Glocker B, Dressler O, Stone G, Onuma Y

October 25, 2019 | 10.4244/EIJ-D-19-00543A

The SYNTAX score on its way out or … towards artificial intelligence: part II

October 25, 2019 | 10.4244/EIJ-D-19-00543B

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Tomaniak M, Storey R, Serruys P

October 9, 2019 | 10.4244/EIJY19M10_01

The EuroIntervention health check 2019

Mylotte D, Byrne R, Capodanno D, Søndergaard L, Vahanian A, Serruys P

October 4, 2019 | 10.4244/EIJV15I9A135

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

Sex differences in clinical outcomes following bioresorbable scaffold implantation: a paradigm shift?

Bourantas C, Bajaj R, Tufaro V, Kilic Y, Serruys P

September 20, 2019 | 10.4244/EIJV15I7A105

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Seth A, Onuma Y, Chandra P, Bahl V, Manjunath C, Mahajan A, Kumar V, Goel P, Wander G, Kaul U, Ajit Kumar V, Abizaid A, Serruys P

September 20, 2019 | 10.4244/EIJ-D-19-00324

Predictors of long-term adverse events after Absorb bioresorbable vascular scaffold implantation: a 1,933-patient pooled analysis from international registries

Caixeta A, Campos C, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, Costa Jr J, Onuma Y, van Geuns R, Bartorelli A, Colombo A, Tamburino C, Serruys P, Abizaid A

September 20, 2019 | 10.4244/EIJ-D-16-00796

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

This week's JAA's: Transcatheter therapy after ASD closure, LAmbre for occluding LAAA & more

January 28, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

Patrick Serruys

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke